Home › Funds › MIC Capital Management UK LLP › RXRX
MIC Capital Management UK LLP position in RXRX
RECURSION PHARMACEUTICALS IN · Health Care
MIC Capital Management UK LLP reported holding 8,255,144 shares of RXRX (RECURSION PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$34.1M, representing 7.36% of its reported portfolio and ranking #3 among its reported holdings. MIC Capital Management UK LLP has disclosed RXRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How MIC Capital Management UK LLP's RXRX position evolved
MIC Capital Management UK LLP first disclosed a stake in RXRX in Q3 2023 at 8,451,758 shares (US$64.7M). The position peaked in Q1 2024 at 8,451,758 shares, worth US$84.3M. Across 13 filings, MIC Capital Management UK LLP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 8,255,144 shares valued at US$34.1M — a reduction of -1,388,889 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 8.45M | $64.66M | New |
| Q4 2023 | 8.45M | $83.33M | Hold |
| Q1 2024 | 8.45M | $84.26M | Hold |
| Q2 2024 | 8.45M | $63.39M | Hold |
| Q3 2024 | 8.45M | $55.70M | Hold |
| Q4 2024 | 9.64M | $65.19M | Add |
| Q1 2025 | 9.64M | $51.02M | Hold |
| Q2 2025 | 9.64M | $48.80M | Hold |
| Q3 2025 | 9.64M | $47.06M | Hold |
| Q4 2025 | 9.64M | $39.44M | Hold |
| Q1 2026 | 9.64M | $29.61M | Hold |
| Q2 2026 | 9.64M | $35.39M | Hold |
| Q3 2026 | 8.26M | $34.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RXRX and 13F data
RXRX (RECURSION PHARMACEUTICALS IN) is a Health Care company. 27 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$184.8M), SOFTBANK GROUP CORP. (US$50.0M), Data Collective IV GP, LLC (US$21.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RXRX
- ARK Invest 44.75M sh · $184.80M · Q3 2026
- SOFTBANK GROUP CORP. 13.64M sh · $50.05M · Q2 2026
- Data Collective IV GP, LLC 5.94M sh · $21.80M · Q2 2026
- DCVC Opportunity Fund II GP, LLC 3.95M sh · $14.50M · Q2 2026
- IQ EQ FUND MANAGEMENT (IRELAND) Ltd 2.68M sh · $11.06M · Q3 2026
More on MIC Capital Management UK LLP
FAQ
How long has MIC Capital Management UK LLP held RXRX?
MIC Capital Management UK LLP has disclosed RXRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is MIC Capital Management UK LLP's current position in RXRX?
As of Q3 2026, MIC Capital Management UK LLP holds 8.26M shares of RXRX (RECURSION PHARMACEUTICALS IN), valued at $34.09M, representing 7.36% of its reported portfolio and ranking #3.
Has MIC Capital Management UK LLP been buying or selling RXRX?
In the latest 13F filing (Q3 2026), MIC Capital Management UK LLP reduced its position in RXRX. The position peaked in Q1 2024 at 8.45M shares.
Which other funds hold RXRX?
Other major institutional holders of RXRX include ARK Invest, SOFTBANK GROUP CORP., Data Collective IV GP, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.